PROC 0.85 (-12.37%)
LU2376511205Drug ManufacturersDrug Manufacturers - Specialty & Generic

Procaps Group (PROC) Competitor Comparison

We are evaluating the key criteria listed to compare Procaps Group (PROC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - PROC ranking 28 / 54

These are the competitors of Procaps Group in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Theratechnologies THTX
90.54
2. ProPhase Labs PRPH
14.25
3. ANI Pharmaceuticals ANIP
12.5
4. Regencell Bioscience Holdings RGC
12.19
5. Evolus EOLS
10.42
6. Eagle Pharmaceuticals EGRX
9.12
7. Phibro Animal Health PAHC
7.75
8. Alimera Sciences ALIM
7.61
9. Emergent BioSolutions EBS
7.53
10. Vifor Pharma G2AB.F
7.23
11. Alvotech ALVO
6.19
12. Green Thumb Industries R9U2.F
6.1
13. Avadel Pharmaceuticals AVDL
5.98
14. Linc LNC
5.85
15. PetIQ PETQ
5.4
16. Kolinpharma KIP.MI
4.84
17. Ironwood Pharmaceuticals IRWD
4.73
18. Societal CDMO SCTL
3.72
19. Ayr Wellness 3KJB.F
3.68
20. Organogenesis Holdings ORGO
3.36
21. Elanco Animal Health ELAN
3.31
22. Cumberland Pharmaceuticals CPIX
3.27
23. Curaleaf Holdings CURLF
3.2
24. Kamada KMDA
3.18
25. Amneal Pharmaceuticals AMRX
3.15
26. Taro Pharmaceutical Industries TARO
2.87
27. Journey Medical DERM
2.78
28. Procaps Group PROC
2.71
29. Cronos Group CRON
2.69
30. Embecta EMBC
2.61
31. Pacira BioSciences PCRX
2.37
32. Tilray Brands TLRY
2.33
33. Neoleukin Therapeutics NLTX
2.29
34. Catalent CTLT
2.19
35. Teva Pharmaceutical Industries TEVA
2.15
36. Perrigo PRGO
2.08
37. Alpha Teknova TKNO
1.89
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Zynerba Pharmaceuticals ZYNE
1.63
44. Clever Leaves Holdings CLVR
1.62
45. Solid Biosciences SLDB
1.61
46. Bausch Health Companies BHC
1.61
47. Relmada Therapeutics RLMD
1.58
48. Universe Pharmaceuticals UPC
1.58
49. SCYNEXIS SCYX
1.44
50. Collegium Pharmaceutical COLL
1.09
51. Supernus Pharmaceuticals SUPN
1.07
52. Zoetis ZTS
0.79
53. Harrow Health HROW
0.68
54. Amphastar Pharmaceuticals AMPH
0.38

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.